Results 21 to 30 of about 34,978 (296)

Preemptive Therapy in Cryptococcosis Adjusted for Outcomes

open access: yesJournal of Fungi, 2023
Cryptococcosis is one of the most serious opportunistic diseases in patients living with HIV. For this reason, early diagnosis and appropriate treatment are important. Objectives.
Fernando Messina   +5 more
doaj   +1 more source

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

open access: yesInternal medicine journal (Print), 2021
Cryptococcosis caused by the Cryptococcus neoformans–Cryptococcus gattii complex is an important opportunistic infection in people with immunodeficiency, including in the haematology/oncology setting.
Christina C. Chang   +6 more
semanticscholar   +1 more source

Recent Advances in Cryptococcus and Cryptococcosis

open access: yesMicroorganisms, 2021
The members of the Cryptococcus neoformans and Cryptococcus gattii species complexes are the main etiological agents of cryptococcosis, a life-threatening fungal infection affecting mostly immunocompromised people, but also immunocompetent hosts or those
C. Firacative, L. Trilles, W. Meyer
semanticscholar   +1 more source

Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles

open access: yesbioRxiv, 2021
Cryptococcosis, due to infection by fungi of the Cryptococcus neoformans species complex, is responsible for substantial morbidity and mortality in immunocompromised persons, particularly those with AIDS.
C. Specht   +9 more
semanticscholar   +1 more source

Detection of Histoplasma DNA from Tissue Blocks by a Specific and a Broad-Range Real-Time PCR: Tools to Elucidate the Epidemiology of Histoplasmosis

open access: yesJournal of Fungi, 2020
Lack of sensitive diagnostic tests impairs the understanding of the epidemiology of histoplasmosis, a disease whose burden is estimated to be largely underrated.
Dunja Wilmes   +7 more
doaj   +1 more source

Vaccination with recombinant Cryptococcus proteins in glucan particles protects mice against cryptococcosis in a manner dependent upon mouse strain and cryptococcal species [PDF]

open access: yesmBio, 2017
Development of a vaccine to protect against cryptococcosis is a priority given the enormous global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery system, we previously demonstrated that mice vaccinated with crude ...
et al,, Lodge, Jennifer K
core   +3 more sources

Identification of risk factors for disseminated cryptococcosis in non-hiv patients: a retrospective analysis

open access: yesEuropean Journal of Medical Research, 2023
Objective This study aimed to investigate the potential risk factors associated with disseminated cryptococcosis in HIV-negative individuals. Methods A total of 106 HIV-negative patients with cryptococcal disease were enrolled.
Fan Zhang   +3 more
doaj   +1 more source

Direct Inhibition of T-Cell Responses by the Cryptococcus Capsular Polysaccharide Glucuronoxylomannan [PDF]

open access: yes, 2006
The major virulence factor of the pathogenic fungi Cryptococcus neoformans and C. gattii is the capsule. Glucuronoxylomannan (GXM), the major component of the capsule, is a high-molecular-weight polysaccharide that is shed during cryptococcosis and can ...
Lam, Jennifer S   +2 more
core   +4 more sources

Pulmonary cryptococcosis presenting as miliary tuberculosis in an immunocompetent patient

open access: yesThe Journal of Association of Chest Physicians, 2021
Pulmonary Cryptococcosis is a rare and difficult to diagnose entity. It has been found to be associated with immunocompromised patients. Pulmonary Cryptococcosis in an immunocompetent patient is extremely rare condition.
Sharad Joshi   +4 more
doaj   +1 more source

Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant. [PDF]

open access: yesPLoS ONE, 2012
The Infectious Disease Society of America (IDSA) 2010 Clinical Practice Guidelines for the management of cryptococcosis outlined three key populations at risk of disease: (1) HIV-infected, (2) transplant recipient, and (3) HIV-negative/non-transplant ...
Emily W Bratton   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy